Quantcast

Latest epilepsy Stories

2014-03-12 12:29:03

Qudexy(TM) XR Offers Newest Option for Managing Certain Seizure Disorders and Marks the Company's Entrance into the Epilepsy Therapeutic Area MAPLE GROVE, Minn., March 12, 2014 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. (Upsher-Smith), today announced it received approval on March 11, 2014 from the U.S. Food and Drug Administration (FDA) for Qudexy(TM) XR (topiramate) extended-release capsules, a once-daily, broad-spectrum antiepileptic drug specifically engineered to deliver a smooth...

2014-03-03 08:33:04

Seizure Clusters Connect(TM) is an Online Community Designed to Provide Support and Resources for Patients and Caregivers MAPLE GROVE, Minn., March 3, 2014 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. (Upsher-Smith) today announced a new educational program created for patients living with seizure clusters, as well as their families and friends. The initiative--called Seizure Clusters Connect(TM)--uses traditional and social media to offer patients and their caregivers a community for...

2014-02-28 23:31:41

Atlantic NeuroSurgical Specialists’ (ANS) neurosurgeon, Dr Zampella, discusses new treatment options for chronic neurosurgical illnesses within functional neurosurgery. Morristown, NJ (PRWEB) February 28, 2014 Atlantic NeuroSurgical Specialists (ANS) announced today advanced treatment options for their patients through Functional neurosurgery. Functional neurosurgery consists of new and innovative procedures used to treat chronic illnesses such as epilepsy, spasticity, pain, and...

2014-02-27 23:01:44

AA Packaging comments on this breaking story for the Medical Marijuana Industry in Chicago. (PRWEB) February 27, 2014 In a surprising turn of events, parents are lobbying the Illinois state legislature to allow medical marijuana supplements to be available to children. This is in the wake of findings that cannabis oil extract can be used to effectively treat pediatric cases of epilepsy. Although Illinois is one of 20 states that currently allows medical marijuana, its regulations are very...

2014-02-25 08:31:10

LOS ANGELES, Feb. 25, 2014 /PRNewswire/ -- NeuroSigma, Inc. (NeuroSigma), a California-based life sciences company focused on commercialization of its non-invasive Monarch(TM) eTNS(TM) System for the treatment of neurological and neuropsychiatric disorders, announced the appointment of David Hayes, Esq. as Senior Vice President, Chief Administrative Officer, General Counsel and Corporate Secretary. Prior to joining NeuroSigma, Mr. Hayes was a partner at Hayes and Boone, LLP, since...

2014-02-24 16:25:23

Photo Op of Local Leaders CHICAGO, Feb. 24, 2014 /PRNewswire-USNewswire/ -- The common bond of the love of a child with epilepsy will bring three of the most influential leaders in Chicago together for the kick-off fundraising event towards the goal of $1.5 million for research for a cure for epilepsy. Chicago Bears General Manager Phil Emery and Ventas Chairman & CEO Debra A. Cafaro will join Susan Axelrod, founding chair of Citizens United for Research in Epilepsy (CURE), at...

2014-02-21 11:36:15

Two new smart phone applications may help people detect epileptic seizures and get better stroke treatment, according to two studies released today that will be presented at the American Academy of Neurology's 66th Annual Meeting in Philadelphia, April 26 to May 3, 2014. In the first study, an epilepsy app was designed to help non-doctors determine if a person is having an epileptic seizure. "It can often be difficult to determine whether someone is having an epileptic seizure," said...

2014-02-20 08:29:34

Proprietary Technology Provides Automatic Stimulation upon Seizure Detection HOUSTON, Feb. 20, 2014 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX) announced today the CE Mark (Conformité Européenne) approval in Europe for the AspireSR generator, the novel sixth-generation VNS Therapy generator. The AspireSR generator provides the well-established benefits of VNS Therapy, coupled with a new feature - Automatic Stimulation in response to detection of a seizure. Proprietary...

2014-02-19 16:24:40

HOUSTON, Feb. 19, 2014 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX), a global leader in medical devices for the treatment and management of epilepsy, today announced it will participate in the following conferences. Greg Browne, Cyberonics' Chief Financial Officer, will participate in one-on-one meetings with investors during the RBC Capital Markets Global Healthcare Conference in New York on Tuesday, February 25, 2014. No formal presentation is scheduled, and the one-on-one...

2014-02-14 08:25:42

Leading Nongovernmental Funder of Epilepsy Research Awards $450,000 in Grants in Early 2014 CHICAGO, Feb. 14, 2014 /PRNewswire-USNewswire/ -- After receiving a record-high 200 plus applications in 2013, Citizens United for Research in Epilepsy (CURE) is proud to announce its six research grant recipients for the Taking Flight and Innovator awards. The surge in applications is credited to CURE's ongoing efforts to drive the epilepsy research agenda, funding innovative science not...


Word of the Day
siliqua
  • A Roman unit of weight, 1⁄1728 of a pound.
  • A weight of four grains used in weighing gold and precious stones; a carat.
  • In anatomy, a formation suggesting a husk or pod.
  • The lowest unit in the Roman coinage, the twenty-fourth part of a solidus.
  • A coin of base silver of the Gothic and Lombard kings of Italy.
'Siliqua' comes from a Latin word meaning 'a pod.'
Related